Episode 17 – Imaging: data analysis of organoids
Posted: 22 February 2023 | Drug Target Review | No comments yet
Tune into this podcast to hear experts discuss imaging and analysing data from organoids!
Part three of our Organoids Miniseries is now live! In this episode, sponsored by Molecular Devices, we discuss how to analyse complex data obtained from organoids.
This conversation features Dr Angeline Lim, a Senior Applications Scientist at Molecular Devices and Dr David Egan, Co-founder and CEO of Core Life Analytics.
Biomarkers aren’t just supporting drug discovery – they’re driving it
FREE market report
From smarter trials to faster insights, this report unpacks the science, strategy and real-world impact behind the next generation of precision therapies.
What you’ll unlock:
- How biomarkers are guiding dose selection and early efficacy decisions in complex trials
- Why multi-omics, liquid biopsy and digital tools are redefining the discovery process
- What makes lab data regulatory-ready and why alignment matters from day one
Explore how biomarkers are shaping early drug development
Access the full report – it’s free!
Key learning points:
- Examine the differences between analysing three-dimensional and two-dimensional cell models
- Learn about the various types of resources required to analyse organoids
- Discover different kinds of technology to overcome challenges related to data analysis of organoids.
Make sure to subscribe to us wherever you listen to your favourite podcasts! We are available on Apple Podcast, Spotify and Google Podcasts.
Our speakers:
Dr Angeline Lim is a Senior Applications Scientist at Molecular Devices where she specialises in bioimaging and automation. She provides scientific support for the company’s portfolio of ImageXpress® High-Content Imaging Systems and their applications in lab automation, high-throughput phenotypic profiling and 3D models in biology. She has over 10 years of research experience in genetics and cell biology and holds a PhD from the University of California at Santa Cruz, US.
Dr David Egan is Co-founder and CEO of Core Life Analytics, a company dedicated to helping biologists analyse their own data. David Egan has over 20 years of experience in high-throughput screening services in both academia and industry. As he witnessed his clients struggle with the analysis of data from high-content screens, he realised this was a widespread problem. This inspired the development of StratoMineR; an intuitive tool that helps biologists to independently analyse their complex datasets.
